In prostate cancer cell lines, androgen signaling has been reported to induce recruitment of the AR-topoisomerase II beta (TOP2B) complex, which catalyzes DSBs at regulatory regions of AR target genes [20]. The gene discussed is AR; the disease is prostate carcinoma.